Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-05-18 @ 12:30 AM
Study NCT ID:
NCT02908750
Status:
COMPLETED
Last Update Posted:
2022-11-14
First Post:
2016-08-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D5160C00036
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |